KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Incyte (INCY) EBIT Margin (2016 - 2026)

Incyte filings provide 17 years of EBIT Margin readings, the most recent being 23.66% for Q1 2026.

  • For the quarter ending Q1 2026, EBIT Margin rose 417.0% year-over-year to 23.66%, compared with a TTM value of 30.05% through Mar 2026, up 2609.0%, and an annual FY2025 reading of 29.46%, up 2802.0% over the prior year.
  • EBIT Margin hit 23.66% in Q1 2026 for Incyte, up from 22.29% in the prior quarter.
  • The five-year high for EBIT Margin was 43.63% in Q2 2025, with the low at 45.81% in Q2 2024.
  • Median EBIT Margin over the past 5 years was 19.49% (2025), compared with a mean of 16.35%.
  • The sharpest move saw EBIT Margin plummeted -6611bps in 2024, then soared 8944bps in 2025.
  • Year by year, EBIT Margin stood at 7.56% in 2022, then soared by 144bps to 18.48% in 2023, then surged by 38bps to 25.58% in 2024, then decreased by -13bps to 22.29% in 2025, then increased by 6bps to 23.66% in 2026.
  • According to Business Quant data, EBIT Margin over the past three periods came in at 23.66%, 22.29%, and 32.47% for Q1 2026, Q4 2025, and Q3 2025 respectively.